Use of botulinum toxin-A in pain associated with neuromuscular disorders
This report evaluates the use of Botulinum toxin type-A in the control of pain associated with neuromuscular disorders. The efficacy, safety, and appropriate patient selection criteria for BTX treatment of neuromuscular disorders were evaluated based on data published in the peer-reviewed literature
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
St. Paul, MN
Minnesota Dept. of Health
2001, 2001
|
| Series: | Minnesota health technology assessments
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This report evaluates the use of Botulinum toxin type-A in the control of pain associated with neuromuscular disorders. The efficacy, safety, and appropriate patient selection criteria for BTX treatment of neuromuscular disorders were evaluated based on data published in the peer-reviewed literature |
|---|---|
| Item Description: | "Created: July 2001." |
| Physical Description: | 1 online resource |